Rolaids Tablet, Chewable
FDA Label NDC 84126-347

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by The Procter & Gamble Manufacturing Company for the product Rolaids (NDC 84126-347). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, purpose, active ingredient (in each chewable tablet), uses, ask a doctor or pharmacist before use if you are, when using this product, if pregnant or breast feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

If Pregnant Or Breast Feeding,

ask a health professional before use.

Keep Out Of Reach Of Children.

Directions

  • fully chew before swallowing
  • adults and children 12 years and over: 1 chewable tablet as symptoms occur, or as directed by a doctor
  • do not take for symptoms that persist for more than 2 weeks unless advised by a doctor

Inactive Ingredients

acacia, anhydrous citric acid, caprylic/capric triglyceride, carmine, carnauba wax, corn starch, corn syrup, dextrin, FD&C Blue No. 1 Aluminum Lake, FD&C Blue No. 2 Aluminum lake, FD&C Red No. 40 Aluminum Lake, FD&C Yellow No. 6 Aluminum Lake, flavors, hydrogenated coconut oil, maltodextrin, phosphoric acid, potassium sorbate, propylene glycol, shellac, sorbic acid, sorbitol, soy lecithin, sucrose, titanium dioxide, water, white wax

Questions?

Call
1-833-372-2729

* Please review the disclaimer below.